Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Skin Neoplasms × relatlimab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Skin Neoplasms 1 Advanced Biliary Tract Cancer(BTC) 1

Interventions

sulforaphane 1 relatlimab 1 cemiplimab 1 Sunscreening Agents 1 Sirolimus 1 Prednisone 1 Nivolumab 1 Niacinamide 1 Negative-Pressure Wound Therapy 1 Everolimus 1 Dermoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07459543 2026-03-09

A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

Bristol-Myers Squibb

Phase 4 Not yet recruiting

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡